68Ga A9 3202
Alternative Names: 68Ga-A9-3202; 68Ga-A9T-3202; A9-3202Latest Information Update: 17 May 2024
At a glance
- Originator Alpha-9 Oncology
- Class Antineoplastics; Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Malignant melanoma
Most Recent Events
- 02 May 2024 Phase-I clinical trials in Malignant melanoma (Diagnosis) in Australia (IV) (ACTRN12624000085572)